Emory University;Children's Healthcare of Atlanta, Inc.
发明人:
Martin L. Moore,Jia Meng,Anne Hotard,Elizabeth Littauer,Christopher C. Stobart
申请号：
US16263915
公开号：
US20190224306A1
申请日:
2019.01.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
In certain embodiments, the disclosure relates to the polynucleotide sequences of respiratory syncytial virus (RSV). In certain embodiments, the disclosure relates to isolated or recombinant nucleic acids and polypeptides comprising desirable nucleic acid sequences and mutations disclosed herein. In certain embodiments, isolated or recombinant RSV comprising the nucleic acids and polypeptides disclosed herein (e.g., attenuated recombinant RSV) are also provided, as are immunogenic compositions including such nucleic acids, polypeptides, and RSV genomes that are suitable for use as vaccines. Attenuated or killed RSV containing these nucleic acids and mutation in the form of copied nucleic acids (e.g., cDNAs) are also contemplated.
